---
schema-version: v1.2.9
id: ISO10993-11-1993
title:
- content: Biological evaluation of medical devices
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Part 11: Tests for systemic toxicity'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Biological evaluation of medical devices - Part 11: Tests for systemic
    toxicity'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: main
- content: Évaluation biologique des dispositifs médicaux
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Partie 11: Essais de toxicité systémique'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Évaluation biologique des dispositifs médicaux - Partie 11: Essais de
    toxicité systémique'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: main
link:
- content: https://www.iso.org/standard/18972.html
  type: src
- content: https://www.iso.org/contents/data/standard/01/89/18972.detail.rss
  type: rss
type: standard
docid:
- id: ISO 10993-11:1993
  type: ISO
  primary: true
- id: ISO 10993-11:1993(E)
  type: iso-reference
- id: urn:iso:std:iso:10993:-11:stage-95.99
  type: URN
docnumber: '10993'
date:
- type: published
  value: 1993-12
contributor:
- organization:
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
    url: www.iso.org
  role:
  - type: publisher
edition:
  content: '1'
revdate: 1993-12
language:
- en
- fr
script:
- Latn
abstract:
- content: Specifies methodologies for the evaluation of the systemic toxicity potential
    of medical devices which release constituents into the body. Includes, in addition,
    pyrogenicity testing. The methods cited are from international standards, national
    standards, directives and regulations.
  language:
  - en
  script:
  - Latn
  format: text/plain
- content: |2

    La présente partie de l'ISO 10993 fixe des méthodes d'évaluation du potentiel de toxicité systémique des dispositifs médicaux susceptibles de relarguer des constituants dans le corps. Elle comporte, en outre, des essais de pyrogénicité. Les méthodes d'essai citées dans la présente partie de l'ISO 10993 sont issues de Normes internationales, de normes nationales, de directives et de réglementations. La présente partie de l'ISO 10993 concerne le produit proprement dit et/ou les substances relargables. Il est prévu que les essais intéressant les extraits ou les substances relargables soient effectués en choisissant des véhicules d'extraction appropriés permettant une extraction maximale de substances relargables, afin d'effectuer les essais biologiques.
  language:
  - fr
  script:
  - Latn
  format: text/plain
docstatus:
  stage:
    value: '95'
  substage:
    value: '99'
copyright:
- owner:
  - name:
    - content: ISO
  from: '1993'
relation:
- type: updates
  bibitem:
    id: ISO10993-11-2006
    type: standard
    docid:
    - id: ISO 10993-11:2006
      type: ISO
      primary: true
    date:
    - type: circulated
      value: '2006-08-15'
    formattedref:
      content: ISO 10993-11:2006
      format: text/plain
place:
- Geneva
ext:
  schema-version: v1.0.3
  doctype:
    type: international-standard
  editorialgroup:
    technical_committee:
    - name: Biological and clinical evaluation of medical devices
      number: 194
      type: TC
      identifier: ISO/TC 194
  ics:
  - code: 11.100.20
    text: Biological evaluation of medical devices
  structuredidentifier:
    project_number: '18972'
    type: ISO
